177 related articles for article (PubMed ID: 31490754)
1. Prognostic Value of Cystatin C in Acute Ischemic Stroke Patients with Intravenous Thrombolysis.
Shi J; Zhang C; Cao Y; Qu X; Liu H; You S
Curr Neurovasc Res; 2019; 16(4):301-309. PubMed ID: 31490754
[TBL] [Abstract][Full Text] [Related]
2. Effect of the interaction between atrial fibrillation and rt-PA dose on the prognosis of acute ischaemic stroke with intravenous thrombolysis.
Wu H; Liu Y; Miao G; Ge J; You S; Zhang X; Liu H; Zhou Y; Lu T; Cao Y; Shi J
Postgrad Med J; 2023 Jun; 99(1172):588-594. PubMed ID: 37319158
[TBL] [Abstract][Full Text] [Related]
3. Dynamic Changes in Fibrinogen and Prognosis of Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis.
Shi J; Shi R; Qin W; Zhang X; Liu H; Xu J; Liu CF; Cao Y
Neurotox Res; 2020 Oct; 38(3):775-784. PubMed ID: 32572815
[TBL] [Abstract][Full Text] [Related]
4. Time-dependence of NIHSS in predicting functional outcome of patients with acute ischemic stroke treated with intravenous thrombolysis.
Wu Z; Zeng M; Li C; Qiu H; Feng H; Xu X; Zhang H; Wu J
Postgrad Med J; 2019 Apr; 95(1122):181-186. PubMed ID: 30975729
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Values of Prothrombin Time and Inflammation-Related Parameter in Acute Ischemic Stroke Patients After Intravenous Thrombolysis with rt-PA.
Zhao J; Dong L; Hui S; Lu F; Xie Y; Chang Y; Yang B
Clin Appl Thromb Hemost; 2023; 29():10760296231198042. PubMed ID: 37670481
[TBL] [Abstract][Full Text] [Related]
6. Systemic Immune-Inflammation Index Predicts 3-Month Functional Outcome in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis.
Weng Y; Zeng T; Huang H; Ren J; Wang J; Yang C; Pan W; Hu J; Sun F; Zhou X; Qiu H; Gao Y; Gao B; Chi L; Chen G
Clin Interv Aging; 2021; 16():877-886. PubMed ID: 34040364
[TBL] [Abstract][Full Text] [Related]
7. Cystatin C is a potential predictor of unfavorable outcomes for cerebral ischemia with intravenous tissue plasminogen activator treatment: A multicenter prospective nested case-control study.
Chang Z; Zou H; Xie Z; Deng B; Que R; Huang Z; Weng G; Wu Z; Pan Y; Wang Y; Li M; Xie H; Zhu S; Xiong L; Ct Mok V; Jin K; Yenari MA; Wei X; Wang Q
Eur J Neurol; 2021 Apr; 28(4):1265-1274. PubMed ID: 33277774
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of combined uric acid and neutrophil-to-lymphocyte ratio in acute ischemic stroke patients treated with intravenous thrombolysis.
Wang C; Zhou M; Kang T; You S; Cao Y; Kong W; Shi J
BMC Neurol; 2024 May; 24(1):183. PubMed ID: 38822243
[TBL] [Abstract][Full Text] [Related]
9. Increase in neutrophils after recombinant tissue plasminogen activator thrombolysis predicts poor functional outcome of ischaemic stroke: a longitudinal study.
Shi J; Peng H; You S; Liu Y; Xu J; Xu Y; Liu H; Shi R; Cao Y; Liu CF
Eur J Neurol; 2018 Apr; 25(4):687-e45. PubMed ID: 29341345
[TBL] [Abstract][Full Text] [Related]
10. Correlation of Changes in Leukocytes Levels 24 Hours after Intravenous Thrombolysis With Prognosis in Patients With Acute Ischemic Stroke.
Chen J; Zhang Z; Chen L; Feng X; Hu W; Ge W; Li X; Jin P; Shao B
J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2857-2862. PubMed ID: 30064868
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of serum MDA and 4-HNE levels on the occurrence of early neurological deterioration after intravenous thrombolysis with rt-PA IVT in patients with acute ischemic stroke.
Zhang L; Li D; Zhang C; Zhang J; Xu J; Bai L; Xu J; Wang C
J Stroke Cerebrovasc Dis; 2024 Apr; 33(4):107574. PubMed ID: 38214238
[TBL] [Abstract][Full Text] [Related]
12. Minor Nonintracranial Hemorrhage and Poor Prognosis among Stroke Patients Undergoing Intravenous Thrombolysis.
Qin X; Zhao S; Yin L; Dou H; Chen J; Wang Y; Li M; Chen R; Yang G; Liu X; Wang R; Jia X; Bu S; Ma D; Wang B; Li S
J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2383-2386. PubMed ID: 28624140
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of White Blood Cell Counts and C-reactive Protein in Acute Ischemic Stroke Patients After Intravenous Thrombolysis.
Qu X; Shi J; Cao Y; Zhang M; Xu J
Curr Neurovasc Res; 2018; 15(1):10-17. PubMed ID: 29577860
[TBL] [Abstract][Full Text] [Related]
14. Dynamic Decrease in Eosinophil After Intravenous Thrombolysis Predicts Poor Prognosis of Acute Ischemic Stroke: A Longitudinal Study.
Yang D; Huang H; Weng Y; Ren J; Yang C; Wang J; Gao B; Zeng T; Hu J; Pan W; Sun F; Zhou X; Chen G
Front Immunol; 2021; 12():709289. PubMed ID: 34305951
[TBL] [Abstract][Full Text] [Related]
15. The association of admission ionized calcium with outcomes of thrombolysed patients with anterior circulation ischemic stroke.
Qi YL; Wu Q; Li XQ; Zhou ZH; Xia C; Wang XH; Chen HS
Brain Behav; 2023 Jan; 13(1):e2844. PubMed ID: 36479811
[TBL] [Abstract][Full Text] [Related]
16. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.
Huang Y; Sharma VK; Robinson T; Lindley RI; Chen X; Kim JS; Lavados P; Olavarría V; Arima H; Fuentes S; Nguyen HT; Lee TH; Parsons MW; Levi C; Demchuk AM; Bath PM; Broderick JP; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Pandian J; Ricci S; Stapf C; Woodward M; Wang J; Chalmers J; Anderson CS;
Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995
[TBL] [Abstract][Full Text] [Related]
17. Temporal Trends in Intravenous Thrombolysis in Acute Ischemic Stroke: Experience from a Tertiary Care Center in India.
Khurana D; Das B; Kumar A; Kumar S A; Khandelwal N; Lal V; Prabhakar S
J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1266-1273. PubMed ID: 28237123
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Prognosis in Ischemic Stroke Patients Treated with Intravenous Thrombolytic Therapy.
Stefanovic Budimkic M; Pekmezovic T; Beslac-Bumbasirevic L; Ercegovac M; Berisavac I; Stanarcevic P; Padjen V; Jovanović DR
J Stroke Cerebrovasc Dis; 2017 Jan; 26(1):196-203. PubMed ID: 28341074
[TBL] [Abstract][Full Text] [Related]
19. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
Yan X; Hu HT; Liu S; Sun YH; Gao X
Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471
[TBL] [Abstract][Full Text] [Related]
20. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
